Estimating the transfusion risk following total knee arthroplasty. (odpre novo okno)

Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P.

Vir‎: Orthopedics 2012;35(10):e1465-71.

Indeksirano‎: PubMed 23027481

DOI‎: 10.3928/01477447-20120919-13

https://www.ncbi.nlm.nih.gov/pubmed/23027481 (odpre novo okno)

Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. (odpre novo okno)

Bebbington A, Kulkarni R, Roberts P.

Vir‎: J Arthroplasty 2005;20(1):125-6.

Indeksirano‎: PubMed 15660071

DOI‎: 10.1016/j.arth.2004.02.031

https://www.ncbi.nlm.nih.gov/pubmed/15660071 (odpre novo okno)

Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood? (odpre novo okno)

Desai SJ, Wood KS, Marsh J, Bryant D, Abdo H, Lawendy AR, Sanders DW.

Vir‎: Can J Surg 2014;57(5):342-8.

Indeksirano‎: PubMed 25265109

https://www.ncbi.nlm.nih.gov/pubmed/25265109 (odpre novo okno)

Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. (odpre novo okno)

Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, Harkness M, Hay A.

Vir‎: Br J Anaesth 2012;108(1):63-71.

Indeksirano‎: PubMed 22037224

DOI‎: 10.1093/bja/aer326

https://www.ncbi.nlm.nih.gov/pubmed/22037224 (odpre novo okno)